drugset / Trial / NCT04790305
Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Phase 4
Recruiting
1072 enrolled
Fudan University
Huazhong University of Science and Technology · collabLinkDoc Technology (Beijing) Co. Ltd. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a prospective, multicenter, randomized, parallel controlled, open-label study. The primary purpose of this study is to evaluate the efficacy of Huaier Granule on postoperative adjuvant therapy of high-risk early-stage triple-negative invasive ductal carcinoma. The Secondary purposes are to evaluate the safety of long-term use of Huaier granules as postoperative adjuvant treatment of high-risk early-stage triple-negative invasive ductal carcinoma, and the changes of quality of life score after treatment with Huaier granule.
Timeline
- Start
- 2021-06-18
- Primary completion
- 2027-12-31
- Completion
- 2028-07-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Huaier Granule | Traditional medicine (herbal / TCM) | 20 g | Oral |